Pandit Trupti, Pandit Ramesh, Goyal Lokesh
Pediatrics, Nemours Children's Health, Glen Mills, USA.
Medicine, Independent Researcher, Philadelphia, USA.
Cureus. 2022 Oct 13;14(10):e30276. doi: 10.7759/cureus.30276. eCollection 2022 Oct.
Introduction The rapid development of vaccines followed the Coronavirus disease 2019 (COVID-19) pandemic. There is still significant vaccine hesitancy, especially among parents. Large-scale pediatric population-based studies or reviews about vaccine side effects are limited. Data sources and methods The Centers for Disease Control and Prevention (CDC) recommends recipients or their providers notify possible adverse events to the Vaccine Adverse Event Reporting System (VAERS). We evaluated Delaware state data from the VAERS system for the pediatric age group. Results A total of 111 reports were reviewed, with summaries of the reported key side effects discussed, including seizures, myocarditis, stroke, multisystem inflammatory syndrome in children (MIS-C), chest pain, hematuria, menstrual disorder, appendicitis, behavioral and otological side effects, etc. Conclusions We noted the approximate prevalence of reported adverse events to be <0.2%. Further studies with larger sample sizes or those focused on each key side effect are needed to evaluate these side effects in detail. An open discussion about the possible side effects and reinforcing the individual, family, and community benefits are key to promoting COVID-19 vaccine acceptance.
引言 2019 冠状病毒病(COVID-19)大流行之后,疫苗迅速发展。疫苗犹豫现象仍然严重,尤其是在家长当中。关于疫苗副作用的大规模基于儿科人群的研究或综述有限。
数据来源与方法 疾病控制与预防中心(CDC)建议疫苗接种者或其医疗服务提供者向疫苗不良事件报告系统(VAERS)报告可能的不良事件。我们评估了VAERS系统中特拉华州儿科年龄组的数据。
结果 共审查了111份报告,并讨论了所报告的主要副作用摘要,包括癫痫发作、心肌炎、中风、儿童多系统炎症综合征(MIS-C)、胸痛、血尿、月经紊乱、阑尾炎、行为和耳科副作用等。
结论 我们注意到报告的不良事件发生率约为<0.2%。需要进行更大样本量的进一步研究或针对每个主要副作用的研究,以详细评估这些副作用。公开讨论可能的副作用并强调个人、家庭和社区的益处是促进COVID-19疫苗接种的关键。